Drug Discovery News and Research

RSS

The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.

Researchers to create integrated global platform for longevity biotechnology, aging research

Deep Longevity, Inc (DLI), a leader in artificial intelligence for aging and longevity research announced that it had entered into the agreement to be acquired by Regent Pacific to create the integrated global platform for longevity biotechnology and aging research.

4 Sep 2020

New approach can make immunotherapy effective against cancers

If cancer is a series of puzzles, a new study pieces together how several of those puzzles connect to form a bigger picture.

3 Sep 2020

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Researchers in the United States have demonstrated that a drug originally developed as a treatment for cancer exhibits antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

2 Sep 2020

Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications

Porvair Sciences reports on testing that demonstrates how its hydrophilic Vyon® porous plastics exhibit outstanding performance in drug discovery applications due to the high hydrophilic void volume conversion of the materials’ pore structure after a special treatment process.

From Porvair Sciences Limited 2 Sep 2020

Manipulating 3D Printed Organoid Microenvironments

Organoids are 3-dimensional (3D) clusters of stem cells that come together and emulate the microenvironment within individual organs, whether that be liver, kidney, heart, gut or other specific organs.

From Manchester BIOGEL 28 Aug 2020

SARS discovery boots search for COVID-19 drugs

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.

27 Aug 2020

Axol Bioscience appoints Liam Taylor as Chief Executive Officer

Axol Bioscience today announced the appointment of Liam Taylor as CEO. Liam will focus on maximizing its iPSC technologies, products, and services.

From Axol Bioscience Ltd 27 Aug 2020

Dotmatics announces the launch of Bioregister 2020.1

Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced the introduction of Bioregister 2020.1, the latest version of its web-based application for registering sequence-based, chemically modified and structure-less biological entities.

27 Aug 2020

New aging biomarkers to be presented at 7th annual ARDD conference

Deep Longevity, a global science-driven longevity and performance management company utilizing the latest advances in artificial intelligence and aging research will present new research and tools for tracking human biological aging at the 7th annual Aging Research and Drug Discovery (ARDD) conference.

25 Aug 2020

Highly expressed protein in lung cancer cells drives resistance to targeted therapies

A protein highly expressed in lung cancer cells drives resistance to targeted therapies, report researchers at the Medical University of South Carolina in the Journal of Thoracic and Cardiovascular Surgery.

25 Aug 2020

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

Out of all the different approaches available to find new therapies to treat COVID-19, drug repurposing is one of the fastest and safest methods, as the drugs are already being used to treat other conditions therefore leading to fewer chances of adverse reactions.

21 Aug 2020

UIC's first-of-its-kind contraceptive receives FDA approval

A first-of-its-kind contraceptive developed at the University of Illinois Chicago has been approved by the U.S. Food and Drug Administration.

19 Aug 2020

CARE consortium launches to accelerate drug discovery and development for COVID-19

CARE a new consortium supported by the Innovative Medicines Initiative public-private partnership announced its launch today to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2, the virus that causes COVID-19.

19 Aug 2020

Promega introduces new serological antibody test for COVID-19

Promega Corporation today announced the launch of its new serological antibody test for COVID-19 to detect the presence of antibodies against the SARS-CoV-2 virus.

From Promega Corporation 13 Aug 2020

Thermo Fisher Scientific launches two breakthrough imaging filters that take cryo-EM to a new level

Thermo Fisher Scientific, the world leader in serving science, today introduced two breakthrough imaging filters, the Thermo Scientific Selectris Imaging Filter and the Thermo Scientific Selectris X Imaging Filter, taking cryo-electron microscopy to a new level, making it possible to view proteins at true atomic resolution.

From Thermo Fisher Scientific Inc. 13 Aug 2020

UH researcher receives $2.2 million NIH grant to prevent obesity-induced cardiovascular diseases

In the early stages of obesity, endothelial cells - located in the inner layer of the arteries - become dysfunctional and lose their normal protective abilities.

12 Aug 2020

Machine learning helps detect new potential drugs to treat COVID-19

Scientists at the University of California, Riverside, have used machine learning to identify hundreds of new potential drugs that could help treat COVID-19, the disease caused by the novel coronavirus, or SARS-CoV-2.

12 Aug 2020

Scientists design new catalyst to widen the range of target chemical substances for radical reactions

Organocatalysts consisting of organic compounds without metal elements are receiving much attention as next generation catalysts in the hope of reducing environmental burden and coping with exhaustion/rising prices of rare metals.

12 Aug 2020

New technology could serve as more reliable model of amyotrophic lateral sclerosis

A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.

12 Aug 2020

Focusing on human enzymes and not SARS-CoV-2 could help treat COVID-19

Now, breakthrough research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself. The new research could pave the way for effective treatments for a wide range of infectious diseases, including the coronavirus disease (COVID-19).

11 Aug 2020

Drug Discovery News and Research

Further Reading

Researchers to create integrated global platform for longevity biotechnology, aging research

New approach can make immunotherapy effective against cancers

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications

Manipulating 3D Printed Organoid Microenvironments

SARS discovery boots search for COVID-19 drugs

Axol Bioscience appoints Liam Taylor as Chief Executive Officer

Dotmatics announces the launch of Bioregister 2020.1

New aging biomarkers to be presented at 7th annual ARDD conference

Highly expressed protein in lung cancer cells drives resistance to targeted therapies

AI can expedite drug repurposing process for finding COVID-19 therapies, says GlobalData

UIC's first-of-its-kind contraceptive receives FDA approval

CARE consortium launches to accelerate drug discovery and development for COVID-19

Promega introduces new serological antibody test for COVID-19

Thermo Fisher Scientific launches two breakthrough imaging filters that take cryo-EM to a new level

UH researcher receives $2.2 million NIH grant to prevent obesity-induced cardiovascular diseases

Machine learning helps detect new potential drugs to treat COVID-19

Scientists design new catalyst to widen the range of target chemical substances for radical reactions

New technology could serve as more reliable model of amyotrophic lateral sclerosis

Focusing on human enzymes and not SARS-CoV-2 could help treat COVID-19

Enabling smarter drug development with radiolabeled chemistry and metabolism expertise eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo